Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Isolated congenital adermatoglyphia is characterized by lifelong absence of dermatoglyphs (fingerprints and palmoplantar ridges) and follows an autosomal-dominant inheritance with complete penetrance. Linkage analysis localized the phenotype to 4q22, implicating a skin-specific short isoform of SMARCAD1.
Sequencing in one large kindred identified a heterozygous splice-site transversion, c.1281+665G>T, predicted to abolish the conserved donor site of the noncoding exon unique to the skin-specific SMARCAD1 transcript; this variant segregated with disease across all affected relatives (PMID:21820097).
A second study of six unrelated patients uncovered three additional heterozygous splice-site mutations (c.378+2T>C, c.378+5G>C and c.378+1G>A) at the same donor junction, all predicted to result in haploinsufficiency of the skin-specific isoform (PMID:24909267).
The variant spectrum in isolated adermatoglyphia is restricted to single-nucleotide substitutions at this conserved splice donor site; no coding missense or structural variants have been reported. A representative pathogenic allele is c.1281+665G>T (p.?) (PMID:21820097).
Functional assessment using a minigene assay demonstrated aberrant exon skipping and decreased RNA stability of the short SMARCAD1 transcript, confirmed by RT-PCR in patient cells; global expression profiling of SMARCAD1-deficient keratinocytes revealed dysregulation of epidermal differentiation-associated genes, supporting a haploinsufficiency mechanism (PMID:21820097, PMID:24909267).
Together, robust segregation in multiple pedigrees, a consistent splice-site mutation spectrum, and concordant functional data establish a Strong clinical validity for heterozygous SMARCAD1 variants in Isolated Congenital Adermatoglyphia. Key take-home: splice-site disruption of a skin-specific SMARCAD1 isoform causes autosomal-dominant adermatoglyphia, informing molecular diagnosis of fingerprint absence.
Gene–Disease AssociationStrongMultiple independent families with autosomal-dominant inheritance, >6 probands, segregation across 7 relatives, functional concordance Genetic EvidenceStrongOne large family and a case series of six unrelated patients with heterozygous splice-site mutations reaching the genetic evidence cap Functional EvidenceModerateMinigene splicing assay and RT-PCR demonstrate aberrant splicing and reduced stability of the skin-specific SMARCAD1 isoform |